Artrya Limited (AYA.AX) has a MoatMap StockRank of 16/100 based on Quality (30/100), Value (35/100), and Momentum (40/100) factor scores. The current signal is STRONG SELL. Artrya Limited, a small-cap Australian healthcare technology company, lacks sufficient proven business model stability, profitability, and an un-copyable moat to qualify as a 'quality compounder.' No clear asymmetric macro tailwind justifies ignoring these fundamental quality concerns.